Advances in basic and translational research in atrial fibrillation
Philosophical Transactions of the Royal Society B: Biological Sciences · 2023
DOI: 10.1098/rstb.2022.0174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, 2023. Verfasst von Dan Hu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, People's Republic of China. Hauptthemen laut MEDLINE: Atrial Fibrillation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Natural Science Foundation of China.
Abstract (Originalsprache)
Atrial fibrillation (AF) is a very common cardiac arrhythmia with an estimated prevalence of 33.5 million patients globally. It is associated with an increased risk of death, stroke and peripheral embolism. Although genetic studies have identified a growing number of genes associated with AF, the definitive impact of these genetic findings is yet to be established. Several mechanisms, including electrical, structural and neural remodelling of atrial tissue, have been proposed to contribute to the development of AF. Despite over a century of exploration, the molecular and cellular mechanisms underlying AF have not been fully established. Current antiarrhythmic drugs are associated with a significant rate of adverse events and management of AF using ablation is not optimal, especially in cases of persistent AF. This review discusses recent advances in our understanding and management of AF, including new concepts of epidemiology, genetics and pathophysiological mechanisms. We review the current status of antiarrhythmic drug therapy for AF, new potential agents, as well as mechanism-based AF ablation. This article is part of the theme issue ‘The heartbeat: its molecular basis and physiological mechanisms’.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, People's Republic of China.
- Cardiovascular Research Institute of Wuhan University, Wuhan 430060, People's Republic of China.
- Hubei Key Laboratory of Cardiology, Wuhan 430060, People's Republic of China.
- Lankenau Institute for Medical Research, and Lankenau Heart Institute, Wynnwood, PA 19096, USA.
- Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19104, USA.
- Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People's Republic of China.
ORCID-Profile: Dan Hu
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Natural Science Foundation of China
Zitieren
APA
Hu, D., Barajas-Martinez, H., Zhang, Z. H., Duan, H. Y., Zhao, Q. Y., Bao, M. W., Du, Y. M., Burashnikov, A., Monasky, M. M., Pappone, C., Huang, C. X., Antzelevitch, C., & Jiang, H. (2023). Advances in basic and translational research in atrial fibrillation. Philosophical Transactions of the Royal Society B: Biological Sciences. https://doi.org/10.1098/rstb.2022.0174
Vancouver
Hu D, Barajas-Martinez H, Zhang ZH, Duan HY, Zhao QY, Bao MW, et al. Advances in basic and translational research in atrial fibrillation. Philosophical Transactions of the Royal Society B: Biological Sciences. 2023. doi:10.1098/rstb.2022.0174
BibTeX
@article{Hu2023,
author = {Hu, Dan and Barajas-Martinez, Hector and Zhang, Zhong-He and Duan, Hong-Yi and Zhao, Qing-Yan and Bao, Ming-Wei and Du, Yi-Mei and Burashnikov, Alexander and Monasky, Michelle M and Pappone, Carlo and Huang, Cong-Xin and Antzelevitch, Charles and Jiang, Hong},
title = {Advances in basic and translational research in atrial fibrillation},
journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
year = {2023},
doi = {10.1098/rstb.2022.0174}
}
EUVIMED